The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...

MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease ...

The European Commission approves MRK's pneumococcal 21-valent conjugate vaccine, Capvaxive, for pneumococcal vaccination in adults.

Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults: Rahway, New Jersey Friday, March 28, 2025, 09: ...

To protect your child, their doctor will give them the pneumococcal conjugate vaccine (PCV ... The original PCV, named PCV7, was approved in 2000, and PCV13 was approved in 2010. The number in the ...

In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new awareness campaign for pneumococcal pneumonia vaccination. Toward the end ...

The 13-valent pneumococcal conjugate vaccine (PCV13) has obtained the corresponding drug production license and has submitted ...

Immunization programs save millions of lives every year by protecting against preventable diseases. The immune response to ...

Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...

“Our data suggest that microbiota-targeted interventions could mitigate the detrimental effects of early-life antibiotics on ...